dc.contributor.author | Bolayirli, Murat | |
dc.contributor.author | Oz, Buge | |
dc.contributor.author | Gazioglu, Nurperi | |
dc.contributor.author | Akgun-Dar, Kadriye | |
dc.contributor.author | Balci, Huriye | |
dc.contributor.author | Kapucu, Ayşegül | |
dc.date.accessioned | 2021-03-04T12:15:39Z | |
dc.date.available | 2021-03-04T12:15:39Z | |
dc.identifier.citation | Balci H., Akgun-Dar K., Gazioglu N., Kapucu A., Bolayirli M., Oz B., "The relationship between prolactin (PRL), leptin, nitric oxide (NO), and cytokines in patients with hyperprolactinemia", PITUITARY, cilt.12, ss.170-176, 2009 | |
dc.identifier.issn | 1386-341X | |
dc.identifier.other | av_7660aedf-7907-40fc-af10-a43d93b24ac2 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/81291 | |
dc.identifier.uri | https://doi.org/10.1007/s11102-008-0140-4 | |
dc.description.abstract | Leptin is a key mediator in the maintenance of neuroendocrine homeostasis. The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), nitric oxide (NO) levels in patients with hyperprolactinemia. The study consists of 16 consecutive patients with high prolactin (PRL) levels (group I) and a control group of 11 normoprolactinemic patients (group II). Pituitary tumor tissues of patients in groups I and II were analyzed for immunohistochemical (IHC) expression of prolactin and leptin. Group I has significantly higher levels of leptin than group II (P < 0.001). There is a strong correlation between PRL and leptin concentrations in group I. However, there were no statistically significant differences for NO, TNF-alpha, IL-6 between the two groups. IHC staining showed that there was strong immunoreactivity for leptin protein in PRL-secreting pituitary adenomas. Double immunostaining of adenoma tissues with PRL and leptin showed that the adenoma cells expressed both. These findings together are suggestive that leptin co-secretion from a prolactinoma may be the cause of increased serum leptin concentration, independently from the peripheral action of prolactin. | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.title | The relationship between prolactin (PRL), leptin, nitric oxide (NO), and cytokines in patients with hyperprolactinemia | |
dc.type | Makale | |
dc.relation.journal | PITUITARY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 12 | |
dc.identifier.startpage | 170 | |
dc.identifier.endpage | 176 | |
dc.contributor.firstauthorID | 1044930 | |